C29H43NO4
Neat
469.7
-20°C
Room Temperature
N-(3-N-Butyl)norbuprenorphine; 90387-35-2; Buprenorphine EP Impurity H; [5a, 7a(S)]-17-Butyl-a-(1, 1-dimethylethyl)-4, 5-epoxy-18, 19-dihydro-3-hydroxy-6-methoxy-a-methyl-6, 14-ethenomorphinan-7-methanol; (2S)-2-[17-butyl-4, 5a-epoxy-3-hydroxy-6-methoxy-6a, 14-ethano-14a-morphinan-7a-yl]3, 3-dimethylbutan-2-ol; Buprenorphine Imp. H (EP); 2CCA2UA7DQ; SCHEMBL19120384; N-(3-N-Butyl)-Norbuprenorphine; FN179890; BUPRENORPHINE IMPURITY H [EP IMPURITY]; BUPRENORPHINE HYDROCHLORIDE IMPURITY H [EP IMPURITY]; (2S)-2-[17-butyl-4, 5alpha-epoxy-3-hydroxy-6-methoxy-6alpha, 14-ethano-14alpha-morphinan-7alpha-yl]3, 3-dimethylbutan-2-ol; (alphaS, 5alpha, 7alpha)-17-Butyl-alpha-(1, 1-dimethylethyl)-4, 5-epoxy-18, 19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-6, 14-ethenomorphinan-7-methanol; 6, 14-Ethenomorphinan-7-methanol, 17-butyl-alpha-(1, 1-dimethylethyl)-4, 5-epoxy-18, 19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, (alphaS, 5alpha, 7alpha)-; 6, 14-Ethenomorphinan-7-methanol, 17-butyl-alpha-(1, 1-dimethylethyl)-4, 5-epoxy-18, 19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, [5alpha and 7alpha(S)]-
(1S, 2S, 6R, 14R, 15R, 16R)-5-butyl-16-[(2S)-2-hydroxy-3, 3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12, 8.01, 6.02, 14.012, 20]icosa-8(20), 9 and 11-trien-11-ol
InChI=1S/C29H43NO4/c1-7-8-14-30-15-13-28-22-18-9-10-19(31)23(22)34-24(28)29(33-6)12-11-27(28,21(30)16-18)17-20(29)26(5,32)25(2,3)4/h9-10,20-21,24,31-32H,7-8,11-17H2,1-6H3/t20-,21-,24-,26+,27-,28+,29-/m1/s1